CCND1 and thyroid cancer: Our studies identified Cyclin D1 as a therapeutic target for thyroid tumors, and provide a rationale for preclinical and clinical studies aimed to assess the efficacy of inhibitors of Cyclin D1 function in thyroid cancer.